ESACT2022 motto (Advanced Cell Technologies: Making Protein, Cell, and Gene Therapies a Reality) reflects all the challenges set out with the establishment of ESACT for advancing the implementation and use of technologies that revolutionise a medical revolution. As at previous ESACT conferences, the program will be designed to provide access to the latest innovations, advances, tools and equipment in Cell Technology.
Presentations & Posters
Join us for the following posters sessions, and learn more about our technologies first hand with Pall Experts. Take the opportunity to meet us.
Senior Bioreactor Application Specialist - SLS - Pall Corporation
Evaluation of the Pall’s Allegro™ STR bioreactor for use in cultivation of mammalian suspension cells and lentiviral vector production
Targeting cost-effective large-scale manufacturing for r-AAV vectors by transient transfection using Pall’s Allegro™ STR bioreactors
Commercial Development Manager - Gene Therapy - Pall Corporation
Scale up of a Lentiviral Production Process from the iCELLis® Nano Bioreactor to the iCELLis 500 + Bioreactor
Pall Booth: We are glad to invite you to visit Pall Corporation at booths 48+49+52+53 HALL 2 in order to learn more about our product portfolio.
Would you like project yourself in your future facility, design an end-to-end process, streamline operations and reduce development time?
Join us on booth 35 at bioProcessUK conference - 15-17 November 2022 in Edinburgh - to experience Accelerator Vision Platform!